PPT-Genetic Testing in the Age of Multigene Panels

Rebecca Pollack MS CGC Rocky Mountain Oncology Identify patients who are appropriate for genetic testing Discuss benefits and limitations of Next Generation Sequencing NGS Review emerging hereditary cancer syndromes. Developed by . Ms. . Shawna . Morrison, . Dr. June Carroll, . and . Dr. Judith . Allanson. Last updated . May 2016. Disclaimer. This presentation is for educational purposes only and should not be used as a substitute for clinical judgement. GEC-KO aims to aid the practicing clinician by providing informed opinions regarding genetic services that have been developed in a rigorous and evidence-based manner. Physicians must use their own clinical judgement in addition to published articles and the information presented herein. GEC-KO assumes no responsibility or liability resulting from the use of information contained herein. . Risks and Benefits of Knowing Your Genetic Makeup. Julie Hopp. Genetic Screening: Who Should Be Tested. CDC’s 2004 Science Ambassador Program. Overview. Genetics Review. Types of Genetic Disorders. Ben Ho Park MD PhD. Johns Hopkins University. Financial Disclosures. I have financial relationships with commercial entities that are relevant to the content of this presentation.. Royalties from Horizon Discovery, LTD. We have one 12m SMA to Limo cable that we will use for testing. Others will come soon. . Alexi has made us a PMT testing box for testing 3 PMTs at a time. It has a nice optical input for bringing in a laser or LED pulse. . Laura . K. Fisher. , MS, CGC. Director . of Genetic . Counseling. October . 8, 2019. Outline. Genetic counseling. What happens at a genetic counseling appointment? . Who should see a genetic counselor?. Christina Dailey, MS, CGC. Christina Dailey, MS, CGC . M Health Fairview. Program Objectives. At the end of this presentation, the healthcare provider audience for this speaker deck should be able to: . Who is Genetic Services?. Administrative Staff . Genetic Counsellors. Clinical Geneticists. Registries (Familial Cancer). Research Nurses . Laboratories. Clinical staff divided into three. different areas:. How common are BRCA1 and BRCA2 mutations in the general population? Inherited mutations in BRCA1 and BRCA2 are relatively uncommon in the general population. The carrier frequency is estimated to rang Patients in the Hereditary Cancer Network Database Background: Mutations in BRCA1 and BRCA2 genes increase an individual’s lifetime risk of breast cancer up to 80 percent, ovarian cancer up to 3 Huntington Society of Canada 151 Frederick St., Suite 400, Kitchener ON N2H 2M2 1-800-998-7398 info@huntingtonsociety.ca www.huntingtonsociety.ca Charitable Registration Number 11896 5516 RR0001 Wh Page 1 of 28 UnitedHealthcare Commercial Medical Policy Effecti ve 10/01/2021 Proprietary Information of UnitedHealthcare. Copyright 202 1 United HealthCare Services, Inc. UnitedHealthcareCommercia Chad Ramsey. Vice President, Policy, Ovarian Cancer Research Alliance. Vanessa Cramer. Director, Policy, Ovarian Cancer Research Alliance. Sponsored by. : Genentech, Inc.. Agenda . Setting the table: Timeline & key terms . January 6, 2020. 1. *Disclaimer: MDA and the contributing authors are not responsible for any changes, edits and redistribution of this program, and are solely responsible for the original copy only, which may be found on mda.org: . Cori Chandler, MPA. Sr. Manager, State & Local Campaigns – Access to Care. Genetic Testing. 2. Genetic Testing. What is it?. The testing of a person’s germline genes. This testing is typically performed using biospecimens such as blood or cells.